Literature DB >> 18278681

Cardiomyogenic potential of human adult bone marrow mesenchymal stem cells in vitro.

P Antonitsis1, E Ioannidou-Papagiannaki, A Kaidoglou, N Charokopos, A Kalogeridis, K Kouzi-Koliakou, I Kyriakopoulou, I Klonizakis, C Papakonstantinou.   

Abstract

BACKGROUND: The aim of this study was to investigate the ability of adult human bone marrow mesenchymal stem cells to differentiate towards a cardiomyogenic phenotype IN VITRO.
METHODS: Bone marrow samples were aspirated from 30 patients undergoing open heart surgery from the anterior iliac crest. Second passaged cells were treated with 10 microM 5-azacytidine. As control groups we used cells not expanded in culture and cells untreated with 5-azacytidine. Morphologic characteristics were analysed by confocal and electron microscopy. The expression of the cytoskeletal protein vimentin and muscle-specific myocin heavy chain was analysed by immunohistochemistry. The expression of the cardiomyocyte specific genes alpha-cardiac actin, beta-myocin heavy chain and cardiac troponin-T was detected by reverse transcriptase polymerase chain reaction.
RESULTS: Mesenchymal stem cells were spindle-shaped with irregular processes. Cells treated with 5-azacytidine assumed a stick-like morphology. They connected with adjoining cells to form myotube-like structures. Numerous myofilaments were detected in induced cells which were immunohistochemically positive for myosin heavy chain and vimentin. The mRNAs of all specific cardiac genes were expressed in both induced and uninduced cells.
CONCLUSION: These results indicate that adult human bone marrow mesenchymal stem cells treated with 5-aza can differentiate towards a cardiomyogenic lineage IN VITRO.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18278681     DOI: 10.1055/s-2007-989328

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  10 in total

1.  What is the oncologic risk of stem cell treatment for heart disease?

Authors:  Konstantinos E Hatzistergos; Arnon Blum; Tan Ince; James M Grichnik; Joshua M Hare
Journal:  Circ Res       Date:  2011-05-27       Impact factor: 17.367

Review 2.  DNA methylation and demethylation link the properties of mesenchymal stem cells: Regeneration and immunomodulation.

Authors:  Tian-Yi Xin; Ting-Ting Yu; Rui-Li Yang
Journal:  World J Stem Cells       Date:  2020-05-26       Impact factor: 5.326

3.  Comparative study of three types of polymer materials co-cultured with bone marrow mesenchymal stem cells for use as a myocardial patch in cardiomyocyte regeneration.

Authors:  Hongxing Niu; Junsheng Mu; Jianqun Zhang; Ping Hu; Ping Bo; Yan Wang
Journal:  J Mater Sci Mater Med       Date:  2013-04-26       Impact factor: 3.896

4.  Myocardial oxygenation and functional recovery in infarct rat hearts transplanted with mesenchymal stem cells.

Authors:  Simi M Chacko; Mahmood Khan; M Lakshmi Kuppusamy; Ramasamy P Pandian; Saradhadevi Varadharaj; Karuppaiyah Selvendiran; Anna Bratasz; Brian K Rivera; Periannan Kuppusamy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-03-13       Impact factor: 4.733

Review 5.  Mechanobiology of cardiomyocyte development.

Authors:  Jeffrey G Jacot; Jody C Martin; Darlene L Hunt
Journal:  J Biomech       Date:  2009-10-12       Impact factor: 2.712

6.  Stem cells isolated from human dental pulp and amniotic fluid improve skeletal muscle histopathology in mdx/SCID mice.

Authors:  Alessandra Pisciotta; Massimo Riccio; Gianluca Carnevale; Aiping Lu; Sara De Biasi; Lara Gibellini; Giovanni B La Sala; Giacomo Bruzzesi; Adriano Ferrari; Johnny Huard; Anto De Pol
Journal:  Stem Cell Res Ther       Date:  2015-08-28       Impact factor: 6.832

7.  Cardiomyogenic Differentiation of Human Dental Follicle-derived Stem Cells by Suberoylanilide Hydroxamic Acid and Their In Vivo Homing Property.

Authors:  Iel-Yong Sung; Han-Na Son; Imran Ullah; Dinesh Bharti; Ju-Mi Park; Yeong-Cheol Cho; June-Ho Byun; Young-Hoon Kang; Su-Jin Sung; Jong-Woo Kim; Gyu-Jin Rho; Bong-Wook Park
Journal:  Int J Med Sci       Date:  2016-10-18       Impact factor: 3.738

Review 8.  Mesenchymal Stem Cell-Based Therapy for Diabetes Mellitus: Enhancement Strategies and Future Perspectives.

Authors:  Haisen Li; Hao Zhu; Ting Ge; Zhifeng Wang; Chao Zhang
Journal:  Stem Cell Rev Rep       Date:  2021-03-05       Impact factor: 5.739

Review 9.  Bone marrow mononuclear stem cells: potential in the treatment of myocardial infarction.

Authors:  Anne-Laure Leblond; John O'Sullivan; Noel Caplice
Journal:  Stem Cells Cloning       Date:  2009-12-04

Review 10.  Current Status and Future Prospects of Genome-Scale Metabolic Modeling to Optimize the Use of Mesenchymal Stem Cells in Regenerative Medicine.

Authors:  Þóra Sigmarsdóttir; Sarah McGarrity; Óttar Rolfsson; James T Yurkovich; Ólafur E Sigurjónsson
Journal:  Front Bioeng Biotechnol       Date:  2020-03-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.